table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
anti-inflammatory therapies
colchicine COLCHIVID Brunetti
stem cells Shi Shu
vilobelimab (IFX-1) PANAMO

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons